Amgen Revenue Surges Past $10B on Key Product Growth

Amgen Inc. [AMGN] recently reported quarterly revenue exceeding $10 billion, driven by strong growth across key products and robust pipeline progress.

The company's landmark clinical results and regulatory advances support future growth, while its disciplined capital allocation and evolving direct-to-consumer (DTC) strategies position the business for long-term success.

During the 24th Annual Global Healthcare Conference, Amgen highlighted its strong revenue growth, with a notable increase in key products. The company's pipeline progress also showed significant advancements, further supporting its future prospects.